Dr. Dave Turner, Senior Director of World Wide R&D at JJVC, and Bart Johnson, Senior Manager R&D at JJVC Jacksonville discuss the science behind the lens, its design, and comparison to other products such as DT1.
Dr. Dave Turner, Senior Director of World Wide R&D at JJVC, and Bart Johnson, Senior Manager R&D at JJVC Jacksonville discuss the science behind the lens, its design, and comparison to other products such as DT1.
In this first interview with Laura Angelini, President, Johnson & Johnson Vision Care, Inc. and Dr. Millicent Knight, Head of Professional Affairs, JJVC we talk about Acuvue Oasys 1-Day, what makes this product launch different from all others, and what it will mean to clinicians and patients.
In this ODwire.org Radio Show, we interview Dr. Faive Kovalis, the founder of SmartOD.com.
The company provides an online site for eye care professionals to directly order frames and lenses WITHOUT the need for sales rep visits or ‘boots on the ground’. This removes a great deal of cost.
Using Zappos as a model, docs can go to the SmartOD.com web site, order product that they want to evaluate, and return any product they don’t want in a pre-paid box.
We get into:
If you have any questions for Dr. Kovalis, please post them here!
In this episode, Adam & Paul continue their conversation with Tom Baker, Business Development Manager at Wells Fargo Practice Finance.
We discuss your financial profile — which is the “snapshot” that banks use to determine your eligibility for loans, as well as the interest rates you’ll pay.
Tom gives advice on how to “tune up” your profile, how to detect (and correct) inaccuracies, and the types of entries that impact your profile the most positively and negatively.
This is a great talk, and not just for folks currently going after a loan!
Ask Tom any follow-up questions in this thread.
In this episode, Adam & Paul continue their conversation with Tom Baker, Business Development Manager at Wells Fargo Practice Finance.
When starting a new practice, you need help — and lots of it!
Professionals such as: Lenders, Attorneys, Accountants, Insurance brokers (… and more) are critical to getting your practice off the ground.
We discuss how to assemble your professional team with Tom, and give you tips for finding the right folks.
Ask Tom any follow-up questions in this thread!
In this episode, we sit down with Dr. Barry Eiden to discuss how he’s built his dry eye practice.
We focus on a particular instrument, the Keratograph 5M, an advanced corneal topographer, and how he uses it to:
He discusses tips for building your own dry eye practice, and I ask him a tough question:
Should it be the standard of care to perform a thorough meibomian gland evaluation on all dry eye patients?
(Our thanks again to long-time ODwire.org Supporter OCULUS for sponsoring this show!)
Blepharitis remains a significant source of discomfort for patients, and over the years docs have tried a variety of therapeutic approaches to treating the problem.
In this ODwire.org Radio show, we talk with Walter O. Whitley, OD, Director of Optometric Services at Virginia Eye Consultants about:
Please share your experience with ODwire.org members in the thread below, and if you have any questions for Dr. Whitley, ask them here.
Biologic therapies (using substances made from living organisms to treat disease) are the latest cutting-edge tool that you can implement in your practice to improve patient outcomes.
In this ODwire.org Radio show, we sit down with Nick Colatrella, OD, FAAO to discuss:
We also talk more in-depth with Dr. Colatrella about PROKERA®, a biologic corneal bandage composed of preserved amniotic membrane tissue.
Docs who want to provide leading-edge care to their patients & differentiate themselves should take a listen to this show!
Please discuss your experiences with biologic therapies in the thread below, Dr. Colatrella can answer any follow-up questions here!
We’re taught in school that generic drugs are identical to their brand-name equivalents.
But is that true? Are generics actually identical, or do differences in their composition and production processes lead to different clinical outcomes?
In this important ODwire.org Radio show, experienced clinicians Drs. Mel Friedman and Agustin Gonzalez talk about their research into this issue, and what you as a clinician should know when you write for generics vs. branded pharmaceuticals.
If you engage in patient care (or regularly take pharmaceuticals yourself), this is one episode you won’t want to miss!
Frequent ODwire.org contributor Dr. Richard Frankel discusses how ODs can profit from the Affordable Care Act, and the nuts-and-bolts of joining an Accountable Care Organization (ACO), which is a critical program for expanding your patient base & ensuring you won’t be left behind.
*** IMPORTANT: The deadline for clinicians joining an ACO & participating in 2015 is August 17, 2014. You need to hurry up & get the process started to avoid being left out.
Listen to the radio show for instructions on how to get started & read the discussion thread.